Lack of association between the MEF2A gene and myocardial infarction

Circulation

Volumn 117, Issue 2, 2008, Pages 185-191

  Lieb, Wolfgang ^a   Mayer, Björn ^a   König, Inke R ^a   Borwitzky, Iris ^a   Götz, Anika ^a   Kain, Silke ^b   Hengstenberg, Christian ^c   Linsel Nitschke, Patrick ^a   Fischer, Marcus ^c   Döring, Angela ^d   Wichmann, H Erich ^d,e   Meitinger, Thomas ^d,f   Kreutz, Reinhold ^b   Ziegler, Andreas ^a   Schunkert, Heribert ^a   Erdmann, Jeanette ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary disease; Epidemiology; Genetics; Myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; CORONARY RISK; FAMILY STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEF2A GENE; PEDIGREE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; HUMANS; INHERITANCE PATTERNS; MADS DOMAIN PROTEINS; MYOCARDIAL INFARCTION; MYOGENIC REGULATORY FACTORS; POLYMORPHISM, GENETIC;

EID: 38049144096     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.728485     Document Type: Article

References (26)

1. Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol. 2007;96:1-7.
2. Topol EJ, Smith J, Plow EF, Wang QK. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet. 2006;15:R117-R123.
3. Incalcaterra E, Hoffmann E, Averna MR, Caimi G. Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol. 2004;52:287-312.
4. Broeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, Blangero J, Nurnberg P, Reis A, Riegger GA, Jacob HJ, Schunkert H. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet. 2002;30:210-214.
5. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367:651-658.
6. Wang Q. Advances in the genetic basis of coronary artery disease. Curr Atheroscler Rep. 2005;7:235-241.
7. Dedoussis GV, Schmidt H, Genschel J. LDL-receptor mutations in Europe. Hum Mutat. 2004;24:443- 459.
8. Pisciotta L, Hamilton-Craig I, Tarugi P, Bellocchio A, Fasano T, Alessandrini P, Bon GB, Siepi D, Mannarino E, Cattin L, Averna M, Cefalu AB, Cantafora A, Calandra S, Bertolini S. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. Atherosclerosis. 2004;172:309-320.
9. Ikewaki K, Matsunaga A, Han H, Watanabe H, Endo A, Tohyama J, Kuno M, Mogi J, Sugimoto K, Tada N, Sasaki J, Mochizuki S. A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis. 2004;172:39-45.
10. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 2003;302:1578-1581.
11. Bhagavatula MRK, Fan C, Shen GQ, Cassano J, Plow EF, Topol EJ, Wang Q. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet. 2004;13:3181-3188.
12. Weng L, Kavaslar N, Ustaszewska A, Doelle H, Schackwitz W, Hebert S, Cohen JC, McPherson R, Pennacchio LA. Lack of MEF2A mutations in coronary artery disease. J Clin Invest. 2005;115:1016-1020.
13. Kajimoto K, Shioji K, Tago N, Tomoike H, Nonogi H, Goto Y, Iwai N. Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ J. 2005;69:1192-1195.
14. Gonzalez P, Garcia-Castro M, Reguero JR, Batalla A, Ordonez AG, Palop RL, Lozano I, Montes M, Alvarez V, Coto E. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet. 2006;43:167-169.
15. Han Y, Yang Y, Zhang X, Yan C, Xi S, Kang J. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population. Clin Chem Lab Med. 2007;45:987-992.
16. Mayer B, Fischer M, Erdmann J, Holmer S, Lieb W, Hubauer U, Klein G, Loewel H, Nuernberg G, Nuernberg P, Saar K, Reis A, Broeckel U, Jacob H, Hengstenberg C, Schunkert H. Identification of rare forms of autosomal dominant heritability of myocardial infarction. Circulation. 2002;106(suppl II):II-290. Abstract.
17. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, Erdmann J, Klein G, Riegger G, Jacob HJ, Schunkert H. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation. 2005;111:855-862.
18. Lowel H, Meisinger C, Heier M, Hormann A. The population-based acute myocardial infarction (AMI) registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen. 2005;67(suppl 1):S31-S37.
19. Lieb W, Graf J, Gotz A, Konig IR, Mayer B, Fischer M, Stritzke J, Hengstenberg C, Holmer SR, Doring A, Lowel H, Schunkert H, Erdmann J. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men: results of the MONICA Augsburg echocardiographic substudy. J Mol Med. 2006;84:88-96.
20. Wichmann HE, Gieger C, Illig T, for the MONICA/KORA Study Group. KORA-gen: resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(suppl 1):S26-S30.
21. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation. 2002;105:310-315.
22. Kreutz R, Hubner N, James MR, Bihoreau MT, Gauguier D, Lathrop GM, Ganten D, Lindpaintner K. Dissection of a quantitative trait locus for genetic hypertension on rat chromosome 10. Proc Natl Acad Sci U S A. 1995;92:8778-8782.
23. Becker T, Knapp M. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet. 2004;75:561-570.
24. Horan PG, Allen AR, Hughes AE, Patterson CC, Spence M, McGlinchey PG, Belton C, Jardine TC, McKeown PP. Lack of MEF2A Delta7aa mutation in Irish families with early onset ischaemic heart disease: a family based study. BMC Med Genet. 2006;7:65.
25. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315:525-528.
26. Zhang L, Vincent GM, Baralle M, Baralle FE, Anson BD, Benson DW, Whiting B, Timothy KW, Carlquist J, January CT, Keating MT, Splawski I. An intronic mutation causes long QT syndrome. J Am Coll Cardiol. 2004;44:1283-1291.